60 results
Keyword Evotaz Remove keyword
-
List item
Opinion/decision on a Paediatric investigation plan (PIP): Evotaz, cobicistat, atazanavir (sulfate)
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: EMEA-001465-PIP01-13-M04, Route(s) of administration: Oral use, Pharmaceutical form(s): Film-coated tablet, Age-appropriate oral solid dosage form
Decision date: 31/01/2022, Last updated: 17/04/2023, Compliance check: XInvented name Evotaz Active substance cobicistat … sulphate) / cobicistat (Evotaz), (EMEA-001465-PIP01-13-M04 … sulphate) / cobicistat (Evotaz), (EMEA-001465-PIP01-13-M04 … -
List item
Human medicine European public assessment report (EPAR): Evotaz
cobicistat, atazanavir, HIV Infections
Date of authorisation: 13/07/2015, Revision: 14, Authorised, Last updated: 25/04/2023Evotaz Blood-Borne Infections Communicable … Evotaz … EMA/355388/2021 EMEA/H/C/003904 Evotaz (atazanavir / cobicistat … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2015
CHMP, Last updated: 22/05/2015Evotaz … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 May 2021
CHMP, Last updated: 21/05/2021Blincyto, Eucreas, Evotaz, Galvus, Icandra, Jalra, Jardiance … -
List item
Press release: Updated advice on body fat changes and lactic acidosis with HIV medicines
CHMP, Last updated: 23/10/2015Emtriva, Epivir, Eviplera, Evotaz, Intelence, Invirase, Kaletra … Emtriva, Epivir, Eviplera, Evotaz, Intelence, Invirase, Kaletra … -
List item
Human medicine European public assessment report (EPAR): Tybost
cobicistat, HIV Infections
Date of authorisation: 19/09/2013, Revision: 15, Authorised, Last updated: 14/02/2023product information for Evotaz, Genvoya, Stribild or Tybost … -
List item
Human medicine European public assessment report (EPAR): Reyataz
atazanavir (as sulfate), HIV Infections
Date of authorisation: 01/03/2004, Revision: 53, Authorised, Last updated: 17/10/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2019
CHMP, Last updated: 18/10/2019Evotaz … -
List item
PRAC recommendations on safety signals (updated)
Last updated: 08/05/2023 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 17/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 27-30 March 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 27/03/2023 to 30/03/2023, Last updated: 22/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 23/01/2023 to 26/01/2023, Last updated: 14/04/2023 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 31/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 17/05/2021 to 20/05/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-29 January 2021
Virtual meeting, from 25/01/2021 to 29/01/2021, Last updated: 04/03/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 23-26 November 2020
Virtual meeting, from 23/11/2020 to 26/11/2020, Last updated: 27/11/2020 -
List item
Expert meeting on paediatric development of fixed-dose combinations for the treatment of the human immunodeficiency virus (HIV)
European Medicines Agency, London, UK, 10/11/2015, Last updated: 05/01/20162014 No (2017) ATV/COBI (Evotaz) 2014 No (2019) FTC/TAF … N/A > 6 years ATV/COBI (Evotaz) 2014 No > 3 months FTC/TAF … N/A > 6 years ATV/COBI (Evotaz) 2014 No > 3 months FTC/TAF … -
List item
Committee for Medicinal Products for Human Use (CHMP): 6-9 November 2017
European Medicines Agency, London, UK, from 06/11/2017 to 09/11/2017, Last updated: 06/01/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2018
European Medicines Agency, London, UK, from 05/02/2018 to 08/02/2018, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 November 2017
European Medicines Agency, London, UK, from 27/11/2017 to 30/11/2017, Last updated: 27/11/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 03/05/2021 to 06/05/2021, Last updated: 27/02/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2018
European Medicines Agency, London, UK, from 19/02/2018 to 22/02/2018, Last updated: 06/04/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2017
European Medicines Agency, London, UK, from 23/01/2017 to 26/01/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 October 2017
European Medicines Agency, London, UK, from 09/10/2017 to 12/10/2017, Last updated: 06/01/2014